Diabetic gastroparesis

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1 Phase I (Other): 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Vanda Pharmaceuticals Inc. Commercial
    TRADIPITANT
    2023-503802-35-00 2 countries 2023 n=70
    Ended

Phase I (Other)

1 trial
  • Dr. Falk Pharma GmbH Commercial
    IMP not specified
    2024-516197-30-00 3 countries 2025 n=60
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Dr. Falk Pharma GmbH Commercial 1 Phase I (Other) 1
Vanda Pharmaceuticals Inc. Commercial 1 Phase III 0
New trials by year
2023
1
2025
1
← All indication landscapes